Stock Yards Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.46M Sell
73,499
-2,156
-3% -$126K 0.14% 96
2025
Q4
$4.08M Sell
75,655
-2,205
-3% -$106K 0.12% 100
2025
Q3
$3.51M Sell
77,860
-6,852
-8% -$320K 0.11% 114
2025
Q2
$3.92M Sell
84,712
-3,027
-3% -$149K 0.13% 96
2025
Q1
$5.35M Sell
87,739
-5,013
-5% -$292K 0.19% 82
2024
Q4
$5.25M Sell
92,752
-3,563
-4% -$199K 0.18% 80
2024
Q3
$4.98M Sell
96,315
-10,039
-9% -$471K 0.16% 88
2024
Q2
$4.42M Sell
106,354
-12,660
-11% -$566K 0.15% 94
2024
Q1
$6.45M Sell
119,014
-1,212
-1% -$61.7K 0.21% 76
2023
Q4
$6.17M Sell
120,226
-35,760
-23% -$1.88M 0.22% 80
2023
Q3
$9.05M Sell
155,986
-172,254
-52% -$10.6M 0.35% 65
2023
Q2
$21M Buy
328,240
+3,426
+1% +$230K 0.77% 41
2023
Q1
$22.5M Buy
324,814
+561
+0.2% +$39.6K 0.86% 38
2022
Q4
$23.3M Sell
324,253
-1,761
-0.5% -$133K 0.92% 35
2022
Q3
$23.2M Buy
326,014
+3,194
+1% +$232K 0.99% 30
2022
Q2
$24.9M Buy
322,820
+57,452
+22% +$4.38M 1.02% 31
2022
Q1
$19.4M Buy
265,368
+8,741
+3% +$587K 1.08% 38
2021
Q4
$16M Buy
256,627
+21,943
+9% +$1.29M 0.84% 46
2021
Q3
$13.9M Sell
234,684
-179
-0.1% -$11.8K 0.88% 46
2021
Q2
$15.7M Buy
234,863
+5,078
+2% +$331K 1% 44
2021
Q1
$14.5M Buy
229,785
+923
+0.4% +$57.4K 0.98% 43
2020
Q4
$14.2M Buy
228,862
+4,205
+2% +$259K 1.03% 38
2020
Q3
$13.5M Sell
224,657
-4,234
-2% -$255K 1.12% 38
2020
Q2
$13.5M Buy
228,891
+2,701
+1% +$162K 1.19% 35
2020
Q1
$12.6M Buy
226,190
+838
+0.4% +$51.2K 1.34% 32
2019
Q4
$14.5M Buy
225,352
+4,315
+2% +$247K 1.23% 31
2019
Q3
$11.2M Buy
221,037
+9,823
+5% +$462K 1.02% 39
2019
Q2
$9.58M Buy
211,214
+354
+0.2% +$16.5K 0.9% 42
2019
Q1
$10.1M Buy
210,860
+21,695
+11% +$1.08M 0.98% 41
2018
Q4
$9.83M Buy
189,165
+139,306
+279% +$7.48M 1.09% 36
2018
Q3
$3.1M Buy
49,859
+2,139
+4% +$127K 0.32% 67
2018
Q2
$2.64M Sell
47,720
-1,790
-4% -$96.7K 0.29% 72
2018
Q1
$3.13M Sell
49,510
-1,841
-4% -$118K 0.35% 64
2017
Q4
$3.15M Sell
51,351
-2,103
-4% -$132K 0.35% 64
2017
Q3
$3.41M Sell
53,454
-1,804
-3% -$105K 0.4% 60
2017
Q2
$3.08M Sell
55,258
-1,233
-2% -$67.1K 0.37% 62
2017
Q1
$3.07M Sell
56,491
-4,617
-8% -$253K 0.39% 63
2016
Q4
$3.57M Sell
61,108
-65
-0.1% -$3.55K 0.47% 58
2016
Q3
$3.3M Sell
61,173
-513
-0.8% -$33K 0.45% 65
2016
Q2
$4.54M Sell
61,686
-170
-0.3% -$12K 0.6% 57
2016
Q1
$3.95M Sell
61,856
-2,162
-3% -$136K 0.56% 60
2015
Q4
$4.4M Sell
64,018
-2,092
-3% -$138K 0.61% 56
2015
Q3
$3.91M Sell
66,110
-1,646
-2% -$104K 0.6% 57
2015
Q2
$4.51M Sell
67,756
-1,166
-2% -$76.8K 0.64% 56
2015
Q1
$4.45M Sell
68,922
-5,823
-8% -$365K 0.63% 55
2014
Q4
$4.41M Buy
74,745
+1,522
+2% +$85.8K 0.63% 55
2014
Q3
$3.75M Sell
73,223
-3,194
-4% -$160K 0.57% 59
2014
Q2
$3.71M Sell
76,417
-17,007
-18% -$838K 0.53% 61
2014
Q1
$4.85M Sell
93,424
-521
-0.6% -$27.7K 0.7% 56
2013
Q4
$4.99M Sell
93,945
-1,790
-2% -$91.2K 0.74% 52
2013
Q3
$4.43M Sell
95,735
-1,659
-2% -$72.8K 0.71% 54
2013
Q2
$4.35M Buy
+97,394
New +$4.23M 0.48% 53

Other funds holding BMY

Stock Yards Bank & Trust's BMY Position: Q1 2026 in Review

Stock Yards Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, selling an estimated $126K and leaving 73,499 shares worth $4.46M. The position accounts for 0.14% of the portfolio, ranked #96.

Stock Yards Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.9M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Stock Yards Bank & Trust held 73,499 shares of Bristol-Myers Squibb worth $4.46M as of Q1 2026.
  • Stock Yards Bank & Trust sold 2,156 Bristol-Myers Squibb shares in Q1 2026, an estimated $126K.
  • Bristol-Myers Squibb made up 0.14% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #96 holding.
  • Stock Yards Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Stock Yards Bank & Trust's Bristol-Myers Squibb position peaked at $24.9M in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.